Home > > Global Blood Platelet Market Report
The Blood Platelet market was valued at $153.6 Million in 2023, and is projected to reach $182.0 Million by 2030 growing at a CAGR of 2.50% from 2024 to 2030. Thrombocytopenia segment is expected to be the highest contributor to this market, with $44.1 Million in 2023, and is anticipated to reach $51.9 Million by 2030, registering a CAGR of 2.42%. Platelet Function Disorders segment is anticipated to reach $17.3 Million by 2030 with the highest CAGR of 2.73%. Thrombocytopenia and Perioperative Indications segments collectively expected to account for about 51.3% share of the Blood Platelet market in 2023, with the former constituting around 28.7% share. Platelet Function Disorders and Perioperative Indications segments are expected to witness significant growth rates at a CAGR of 2.73% and 2.50% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 32.0% in the overall Blood Platelet market in 2023, and is anticipated to reach 32.2% by 2030. Application Hemophilia Thrombocytopenia Perioperative Indications Platelet Function Disorders Other Applications End User Hospital Settings Other Users BY REGION North America U.s. Canada Mexico Europe Germany France U.k. Italy Spain Russia Rest of Europe Asia China India Japan Australia South Korea Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA